Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055198
Status:
TERMINATED
Last Update Posted:
2017-06-14
First Post:
2003-02-20
Brief Title:
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Sponsor:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12-19
Start Date Type:
ACTUAL
Primary Completion Date:
2004-01-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-01-26
Completion Date Type:
ACTUAL
First Submit Date:
2003-02-20
First Submit QC Date:
February 20 2003
Study First Post Date:
2003-02-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-12
Last Update Post Date:
2017-06-14
Last Update Post Date Type:
ACTUAL